Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors
Resnic F, Blake G, Ohno-Machado L, Selwyn A, Popma J, Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. The American Journal Of Cardiology 2001, 88: 493-496. PMID: 11524056, DOI: 10.1016/s0002-9149(01)01725-8.Peer-Reviewed Original ResearchMeSH KeywordsAge DistributionAgedAnalysis of VarianceAneurysm, FalseAngioplasty, Balloon, CoronaryAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedArteriovenous FistulaChi-Square DistributionCoronary DiseaseCoronary Vessel AnomaliesCoronary VesselsEquipment SafetyFemaleHematomaHumansIncidenceMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionProbabilityRetrospective StudiesRisk AssessmentRisk FactorsSex DistributionConceptsPercutaneous coronary interventionVascular closure deviceGlycoprotein IIb-IIIa antagonistsVascular complication ratesVascular complicationsClosure deviceCoronary interventionComplication rateLower vascular complication ratesOverall vascular complication rateGlycoprotein IIb-IIIa inhibitorsIIb-IIIa inhibitorsSubgroup of patientsLength of stayHospital stayConsecutive patientsLarge hematomaSurgical repairArteriovenous fistulaPatient populationUnivariate analysisRetrospective analysisComplicationsPatient comfortPatients